Disease Info Card

Dysplastic Nevus Syndrome

Information about Dysplastic Nevus Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Dysplastic Nevus Syndrome

Most recent studies have shown that Dysplastic Nevus Syndrome shares some biological mechanisms with basal-cell-carcinoma, carcinoma, cell-transformation-neoplastic, cutaneous-melanoma, dysplasia, dysplastic-nevus, hereditary-melanoma, hutchinsons-melanotic-freckle, lentigo, malignant-neoplasm-of-skin, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanocytic-nevus, melanoma, neoplasm-metastasis, neoplasms, neoplasms-multiple-primary, precancerous-conditions, skin-neoplasms, xeroderma-pigmentosum.

Among the many pathways, these few ones have gauged particular interests from scientists studying Dysplastic Nevus Syndrome, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Cycle, Cell Growth, Cell Killing, Cell Migration, Cell Motility, Cell Proliferation, Dna Repair, G2 Phase, Hypersensitivity, Immune Response, Localization, Melanocyte Proliferation, Metaphase, Mismatch Repair, Pathogenesis, Pigmentation, Secretion, Senescence

Quite a number of genes have been found to play important roles in Dysplastic Nevus Syndrome, such as BRAF, CDK2, CDK4, CDKN2A, EGF, EGFR, GRP, HRAS, MC1R, MLANA, MLH1, NRAS, PCNA, SYNM, TP53, TYR, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.